Please Wait
Applying Filters...
Filters
×

filter

Sandoo Pharmaceuticals and Chemcials Co.,Ltd

Vasudha Pharma Chem Limited

Zhejiang Huahai Pharmaceutical Co., Ltd.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

124750-51-2

End Use API

Telmisartan

Supporting Information

View All Icon

About the Company

Sandoo Pharmaceuticals and Chemcials Co.,Ltd ...

Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and importing pharmaceutical intermediates and chemical products as well as active pharmaceutical ingredients.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

124750-51-2

End Use API

LOSARTAN POTASSIUM

Supporting Information

View All Icon

About the Company

VASUDHA PHARMA CHEM LIMITED was incorporated ...

VASUDHA PHARMA CHEM LIMITED was incorporated as a public limited company under the Companies Act, 1956 at Hyderabad in the state of Andhra Pradesh, India during the year 1994 - 95. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates for catering to the domestic as well as international market. The company recognized the vital role of R & D for becoming successful in the generic market. Initially, the focus was on development of cost effective processes for several intermediates related to piperidone & piperidine derivatives. By 2003 -04, the company gained world class expertise and became the largest manufacturer of piperidone & piperidine derivatives in the world. Subsequently, the company forward integrated from intermediates of piperidone & piperidine derivatives to APIs and later on diversified into large product portfolio of about 20 APIs spreading across several therapeutic areas. With the strength of its portfolio, the gross sales of the company has grown from INR 0.02 billion (US$ 0.31 million) in FY 1997-98 to INR 4.37 billion (US$ 80.93 million) in FY 2012-13 (considering 1 US$ = INR 54.00). The composition of export sales to gross sales is mostly around 45% due to the importance given to the product quality, timely delivery and competitive pricing. India Ratings & Research Private Limited (A Fitch Group Company) upgraded Vasudha Pharma Chem Limited’s National Long Term Rating to “ IND A– “ with “ Positive outlook ” Short Term Debt Rating to “ IND A1 ” with effect from 05-09-2013. The company has three manufacturing facilities: First manufacturing facility at Jeedimetla, Hyderabad, A.P. has been set up in 1997-98 and subsequently upgraded to cGMP standards in 2006-07. Second manufacturing facility has been set up in Jawaharlal Nehru Pharma City, Visakhapatnam, A.P. with WHO-GMP standards and commenced operations in the FY 2007-08. Third manufacturing facility has also been set up in Jawaharlal Nehru Pharma City, Visakhapatnam, A.P. and commenced operations in the FY 2010-11. The company has already obtained WHO GMP certification for all its leading APIs and obtained COS for three of its APIs. The company has also filed DMFs with USFDA and EDQM for three of its APIs. The company has also filed DMFs for its various products with European, Chinese, Japanese and Russian regulatory authorities.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

124750-51-2

End Use API

LOSARTAN POTASSIUM

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

PharmaCompass >>

First
Previous
Next
Last